Eliem Therapeutics (ELYM) News Today $1.42 +0.05 (+3.65%) As of 07/14/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ELYM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Climb Bio Reports Increased Losses Amid Ongoing DevelopmentMay 15, 2025 | tipranks.comPoint72 Asset Management L.P. Takes Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM)December 10, 2024 | marketbeat.comJanus Henderson Group PLC Boosts Stock Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM)December 8, 2024 | marketbeat.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Sold by Samsara BioCapital LLCDecember 5, 2024 | marketbeat.com278,775 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Purchased by Parkman Healthcare Partners LLCDecember 4, 2024 | marketbeat.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Purchased by Ally Bridge Group NY LLCNovember 28, 2024 | marketbeat.comGreat Point Partners LLC Takes Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM)November 27, 2024 | marketbeat.comEliem Therapeutics (NASDAQ:ELYM) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comEliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.October 2, 2024 | globenewswire.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Sold by Driehaus Capital Management LLCSeptember 30, 2024 | marketbeat.comAffinity Asset Advisors LLC Invests $11.88 Million in Eliem Therapeutics, Inc. (NASDAQ:ELYM)September 25, 2024 | marketbeat.comEliem Therapeutics: Recent Strategic Pipeline RestructuringSeptember 23, 2024 | seekingalpha.comAlly Bridge Group NY LLC Takes $3.56 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM)September 23, 2024 | marketbeat.comEliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation SummitSeptember 11, 2024 | globenewswire.comEliem Therapeutics (NASDAQ:ELYM) Shares Up 4.6%September 6, 2024 | marketbeat.comEliem Therapeutics Announces Additions to its Leadership TeamAugust 26, 2024 | globenewswire.comEliem Therapeutics Reports Second Quarter Financial ResultsAugust 14, 2024 | globenewswire.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest UpdateJuly 26, 2024 | marketbeat.comEliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 69,005 SharesJuly 24, 2024 | insidertrades.comInsider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 60,201 Shares of StockJuly 24, 2024 | insidertrades.comInsider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells SharesJuly 24, 2024 | finance.yahoo.comIQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On MondayJuly 22, 2024 | benzinga.comValerie Morisset Sells 3,207 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) StockJuly 21, 2024 | insidertrades.comInsider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ...July 19, 2024 | sg.finance.yahoo.comEVP, R&D AND CSO Valerie Morisset Sells 50,000 Shares of Eliem Therapeutics Inc (ELYM)July 19, 2024 | finance.yahoo.comValerie Morisset Sells 42,377 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) StockJuly 18, 2024 | insidertrades.comInsider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 42,377 Shares of StockJuly 16, 2024 | marketbeat.comInsider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 5,931 Shares of StockJuly 12, 2024 | insidertrades.comInsider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 50,000 Shares of StockJuly 12, 2024 | insidertrades.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Sees Significant Growth in Short InterestJuly 11, 2024 | marketbeat.comInsider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 12,342 Shares of StockJuly 10, 2024 | insidertrades.comEliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 50,000 SharesJuly 4, 2024 | insidertrades.comRa Capital Management, L.P. Acquires 13,008,546 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) StockJuly 2, 2024 | insidertrades.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Director Buys $49,952,816.64 in StockJuly 1, 2024 | marketbeat.comEliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® IndexesJune 28, 2024 | globenewswire.comEliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private PlacementJune 27, 2024 | globenewswire.comEliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Down 53.5% in MayJune 13, 2024 | marketbeat.comShort Interest in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Rises By 127.2%May 29, 2024 | marketbeat.comEliem Therapeutics Stock (NASDAQ:ELYM), Earnings Estimates, EPS, and RevenueMay 17, 2024 | benzinga.comShort Interest in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Increases By 4,453.8%April 25, 2024 | marketbeat.comBML Capital Management LLC Boosts Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM)April 24, 2024 | marketbeat.comEliem Therapeutics (NASDAQ:ELYM) Trading 0.5% Higher April 23, 2024 | marketbeat.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the FirmApril 15, 2024 | prnewswire.comEliem Therapeutics, Inc.: Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private PlacementApril 12, 2024 | finanznachrichten.deSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODNApril 11, 2024 | stockhouse.comEliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines DealApril 11, 2024 | finance.yahoo.comEnlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals among healthcare moversApril 11, 2024 | msn.comEliem Therapeutics To Buy Tenet Medicines, Plans $120 Mln Private Placement; Stock Up In Pre-marketApril 11, 2024 | markets.businessinsider.comELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to ShareholdersApril 11, 2024 | businesswire.comEliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private PlacementApril 11, 2024 | globenewswire.com Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address ELYM Media Mentions By Week ELYM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELYM News Sentiment▼0.000.99▲Average Medical News Sentiment ELYM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELYM Articles This Week▼00▲ELYM Articles Average Week Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Molecular Partners News Alector News Ventyx Biosciences News Lexeo Therapeutics News Theratechnologies News Black Diamond Therapeutics News ALT5 Sigma News Lyell Immunopharma News Inhibikase Therapeutics News Skye Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELYM) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eliem Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELYM Stock Alerts